Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for Sutro Biopharma, Inc. Common Stock, par value $0.001 per share (STRO).
- Disclosed ownership: 1.3%.
- Date of event: 31 Mar 2026.
MILLENNIUM MANAGEMENT LLC - 31 Mar 2026 SCHEDULE 13G/A Report for Sutro Biopharma, Inc. Common Stock, par value $0.001 per share (STRO)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- STRO
- Shares outstanding
- 16,182,923 shares
- Disclosed Ownership
- 210,378 shares
- Ownership
- 1.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 21 Apr 2026, 17:49:09 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 1.3% ownership in Sutro Biopharma, Inc. Common Stock, par value $0.001 per share (STRO) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 30 Jun 2025.
- Current filing was accepted on 21 Apr 2026, 17:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Millennium Management LLC | 1.3% | 210,378 | 0 | 210,378 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 1.3% | 210,378 | 0 | 210,378 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 1.3% | 210,378 | 0 | 210,378 | /s/ Israel A. Englander | Israel A. Englander |